Innovative development path of ethnomedicines: an overview of ethnomedicines in China
Zhaoyun Zhu , Ting Wang , Dehuan Fu , Yali Gui , Jingkun Wang , Tao Cui
Front. Med. ›› 2016, Vol. 10 ›› Issue (2) : 166 -177.
Innovative development path of ethnomedicines: an overview of ethnomedicines in China
In the long history of disease prevention and treatment, ancestral populations worldwide have gained knowledge and experiences in traditional medicines. For instance, ethnomedicines of Chinese ethnic minorities constitute an important part of traditional medicines. In our study, we firstly clarified the concept of ethnomedicines and the connotations of ethnopharmacology. The particularity of ethnomedicine research were then summed up, and the development profiles of the ethnomedicines of Chinese ethnic minorities were discussed by investigating the current status and existing problems. On this basis, we abstracted the innovative development path of ethnomedicines for the first time, which was found to follows:resource study → standardized development research → industrialization of the achievements and efforts for internationalization. We found that platform establishment and team training are keys to achieving innovative development. Hence, this study provided a basis for ethnomedicine development.
traditional medicines / ethnomedicines / Chinese ethnic minorities / ethnopharmacology / research mode / innovative development path
| [1] |
|
| [2] |
|
| [3] |
World Health Organization. Traditional Medicine Strategy of World Health Organization 2014–2023. Geneva: 2013 |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
Research group of ethnomedicines in Minzu University of China. Ethnomediciens. 1st ed. Beijing: China Economic Publishing House, 2013 (in Chinese) |
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
The herbal medicine markets of major countries. Int Business Daily<Date> 2006-6-9</Date>(008) (in Chinese) |
| [24] |
|
| [25] |
World Health Organization. Traditional Medicine Strategy of World Health Organization 2002–2005. Geneva: 2002 |
| [26] |
|
| [27] |
|
| [28] |
Botanical Drug Review. FDA/CDER SBIA Chronicles<Date> 2015-11-17</Date>:1–2 |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
Yunnan Baiyao Group Co., Ltd. Research and application of Yunnan Baiyao. Kunming: Yunnan Science & Technology Press, 2014 (in Chinese) |
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
Yunnan Baiyao Group Co., Ltd. 2015 Annual Report of Yunnan Baiyao Group Co., Ltd. Kunming: Yunnan Baiyao Group, 2016 (in Chinese) |
| [51] |
Guizhou Yibai Pharmaceutical Co., Ltd. 2015 Annual Report of Guizhou Yibai Pharmaceutical Co., Ltd. Guiyang: Yibai Pharmaceutical, 2016 (in Chinese) |
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
Higher Education Press and Springer-Verlag Berlin Heidelberg
/
| 〈 |
|
〉 |